When exposed to daylight and certain wavelengths of artificial light, nifedipine readily converts to a nitrosophenylpyridine derivative. Exposure to ultra-violet light leads to the formation of a nitrophenylpyridine derivative. Therefore, USP recommends that assays be performed in the dark or under golden fluorescent or other low actinic light. Low actinic glassware should be used1.
N7634
Nifedipine
≥98% (HPLC), powder, L-type Ca²⁺ channel blocker
Oferta disponible
Sinónimos:
1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester
Iniciar sesión para ver los precios por organización y contrato.
Spend $350.000 — Save 5%; Spend $600.000 — Save 10%; Spend $1.000.000 — Save 22%*
Iniciar sesión para comprobar la elegibilidad. Comprar productos subvencionables
Seleccione un Tamaño
Cambiar Vistas
| Talla/SKU | Disponibilidad | Precio |
|---|---|---|
1 g | Comprobar disponibilidad del carrito | $82.100 |
5 g | Comprobar disponibilidad del carrito | $288.000 |
10 g | Fecha estimada de envío14 de septiembre de 2026desdePUDAHUEL | $336.000 |
25 g | Comprobar disponibilidad del carrito | $482.000 $409.700 |
Acerca de este artículo
Fórmula empírica (notación de Hill):
C17H18N2O6
Número CAS:
Peso molecular:
346.33
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
EC Number:
244-598-3
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleNombre del producto
Nifedipine, ≥98% (HPLC), powder
Quality Segment
assay
≥98% (HPLC)
form
powder
color
yellow
solubility
DMSO: soluble, ethanol: soluble
originator
Bayer
storage temp.
2-8°C
SMILES string
COC(=O)C1=C(C)NC(C)=C(C1c2ccccc2[N+]([O-])=O)C(=O)OC
InChI
1S/C17H18N2O6/c1-9-13(16(20)24-3)15(14(10(2)18-9)17(21)25-4)11-7-5-6-8-12(11)19(22)23/h5-8,15,18H,1-4H3
InChI key
HYIMSNHJOBLJNT-UHFFFAOYSA-N
Gene Information
human ... ADORA2A(135), ADORA3(140), CACNA1C(775), CACNA1D(776), CACNA1F(778), CACNA1S(779), CACNA2D1(781), CYP1A2(1544), KCNH1(3756), TTR(7276)
mouse ... Cacna1c(12288)
rat ... Adora1(29290), Adora2a(25369), Cacna1c(24239), Cacna1d(29716), Kcnj1(24521), Kcnn4(65206), Tbxas1(24886)
Application
Nifedipine has been used:
- to evaluate its effect on myenteric neuronal calcium current through R-type calcium channel in guinea pig small intestine
- to evaluate the neuroprotective effect of L-type calcium channel blockers in cholinergic and dopaminergic neurons
- to identify the effect of co-administration of nifedipine (anti-hypertensive drug) along with hypoglycemic drug on human umbilical vein cells (HUVECs)
Biochem/physiol Actions
Nifedipine is a L-type Ca2+ channel blocker; and induces apoptosis in human glioblastoma cells. Nifedipine has neuroprotection activity and protects substantia nigra. Nifedipine has antioxidant potential. Nifedipine downregulates inflammatory cytokines like macrophage inflammatory protein-2 (MIP-2), tumor necrosis factor-α (TNF-α). Nifedipine has antihypertensive properties. Nifedipine inhibits extracellular region of adenosine A2a receptor (ADORA2A) gene.
Features and Benefits
This compound is a featured product for ADME Tox and Cyclic Nucleotide research. Discover more featured ADME Tox and Cyclic Nucleotide products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
This compound is featured on the Calcium Channels and Cyclic Nucleotide-Gated (CNG) and Hyperpolarization Activated Cyclic Nucleotide-Gated (HCN) Channels pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Bayer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
1 of 1
Este artículo | |||
|---|---|---|---|
| description ≥98% (HPLC), powder | description Pharmaceutical Secondary Standard; Certified Reference Material | description British Pharmacopoeia (BP) Reference Standard | description Relatively selective blocker of L-type Ca2+ channels. |
| form powder | form - | form solid | form solid |
| assay ≥98% (HPLC) | assay - | assay - | assay ≥98% (UV) |
| Quality Level 200 | Quality Level 300 | Quality Level - | Quality Level 100 |
| storage temp. 2-8°C | storage temp. 2-30°C | storage temp. 2-8°C | storage temp. 10-30°C |
| solubility DMSO: soluble, ethanol: soluble | solubility - | solubility - | solubility DMSO: soluble, ethanol: soluble |
| color yellow | color - | color - | color yellow |
Still not finding the right product?
Explore all of our products under Nifedipine
Palabra de advertencia
Warning
Códigos de peligro
Indicaciones de precaución
Hazard Classifications
Acute Tox. 4 Oral
Clase de almacenamiento
11 - Combustible Solids
¿Qué está pasando?
WGK 1
Punto de inflamación (°F)
Not applicable
Punto de inflamación (°C)
Not applicable
EPI (equipos de protección individual)
dust mask type N95 (US), Eyeshields, Gloves
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
-
Are there any recommended conditions that Product N7634, Nifidipine, should be used in?
1 answer-
Helpful?
-
-
Are there any recommended dosages for Product N7634, Nifidipine, in vivo and in vitro?
1 answer-
Nifedipine is reported to inhibit Ca2+-sensitive K+ channels at 100 μM1. Doses for different animals have been reported2,3. In randomly growing cultures of aortic cells of rats, nifedipine at 10 μM inhibited cell proliferation. References: 1. Thomas-Young, R.J. et al. Biochim. Biophys. Acta, 1146, 81, (1993). 2. Drug Dosages In Laboratory Animals: A Handbook, 3rd ed., Telford Press. and 3. Borchard, R.E. et al. Drug Dosage in Laboratory Animals, A Handbook, Third Edition, p. 315, The Telford Press, (1990).
Helpful?
-
-
What is the solubility of Product N7634, Nifidipine?
1 answer-
Nifedipine can be dissolved in DMSO at 50 mg/ml1. It is sparingly soluble in absolute ethanol2. Herembert, T. et al., dissolved nifedipine in absolute ethanol (no concentration reported); the maximum ethanol concentration in cultures was 0.2% without any effect of solvent on the cells3. Nifedipine is soluble (g/L, at 20°C) in the following solvents: acetone, 250; methylene chloride, 160; chloroform, 140; ethyl acetate, 50; methanol, 26; ethanol, 17.4 It is practically insoluble in water. The solubilities at 37°C in buffer solutions of different pH values are: pH 4, 0.0058 g/L; pH 7, 0.0056 g/L; pH 9.0, 0.0078 g/L; pH 13, 0.006 g/L1. References: 1. Ali, S.L., Analytical Profiles of Drug Substances, 18, 221, (1989). 2. Martindale, The Extra Pharmacopoeia, 30th ed., 374, (1993). and 3. Herembert, T. et al. Brit. J. Pharmacol., 114, 1703, (1995).
Helpful?
-
-
What is the half life of Product N7634, Nifidipine, in vivo?
1 answer-
After administration by the mouth, the half-life is 2 to 5 hours 1. In plasma, about 92-98% binds to plasma proteins. Nifedipine is completely metabolized. About 70% of a dose is excreted in the urine in 24 hours as metabolites including 5-methoxycarbonyl-2,6-dimethyl-4-(2-nitrophenyl) pyridine-3-carboxylic acid; dimethyl 2,6-dimethyl-4-(2-nitrophenyl pyridine-3,5-dicarboxylate and 2-hydroxymethyl-5-methoxycarbonyl-6-methyl-4-(2-nitrophenyl) pyridine-3-carboxylic acid and its lactone derivative. Up to 15% of a dose is eliminated in the feces as metabolites in 4 days 2. References: 1. Martindale, 29th ed., pgs. 1509-1513. 2. Clarke's Isolation and Identification of Drugs., 2nd ed., p. 811.
Helpful?
-
-
What is the Department of Transportation shipping information for this product?
1 answer-
Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product.
Helpful?
-